A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy

被引:3
|
作者
Verhaart, Ingrid E. C. [1 ]
van de Vijver, Davy [1 ]
Boertje-van der Meulen, Joke W. [1 ]
Putker, Kayleigh [1 ]
Adamzek, Kevin [1 ]
Aartsma-Rus, Annemieke [1 ]
van Putten, Maaike [1 ]
机构
[1] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands
来源
PLOS ONE | 2019年 / 14卷 / 04期
关键词
BODY-MASS INDEX; URSOLIC ACID; MDX MOUSE; PROTEIN; SUPPLEMENTATION; DEGRADATION; PHENOTYPE; GLUTAMINE; STRENGTH; CREATINE;
D O I
10.1371/journal.pone.0215335
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Duchenne muscular dystrophy (DMD) is caused by a lack of dystrophin protein. Next to direct effects on the muscles, this has also metabolic consequences. The influence of nutrition on disease progression becomes more and more recognized. Protein intake by DMD patients may be insufficient to meet the increased demand of the constantly regenerating muscle fibers. This led to the hypothesis that improving protein uptake by the muscles could have therapeutic effects. The present study examined the effects of a modified diet, which composition might stimulate muscle growth, on disease pathology in the D2-mdx mouse model. D2-mdx males were fed with either a control diet or modified diet, containing high amounts of branched-chain amino acids, vitamin D3 and ursolic acid, for six weeks. Our study indicates that the modified diet could not ameliorate the muscle pathology. No effects on bodyweight or weight of individual muscles were observed. Neither did the diet affect severity of fibrosis or calcification of the muscles.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
    Olga Mucha
    Paulina Podkalicka
    Katarzyna Kaziród
    Emilia Samborowska
    Józef Dulak
    Agnieszka Łoboda
    [J]. Skeletal Muscle, 11
  • [2] Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
    Mucha, Olga
    Podkalicka, Paulina
    Kazirod, Katarzyna
    Samborowska, Emilia
    Dulak, Jozef
    Loboda, Agnieszka
    [J]. SKELETAL MUSCLE, 2021, 11 (01)
  • [3] Sildenafil Ameliorates Skeletal Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy
    Percival, Justin
    Whitehead, Nicholas
    Siegel, Michael
    Gray, Heidi
    Adamo, Candace
    Marcinek, David
    Beavo, Joseph
    Froehner, Stanley
    [J]. FASEB JOURNAL, 2011, 25
  • [4] Respiratory Pathology in a Humanized Mouse Model of Duchenne Muscular Dystrophy
    McCall, Angela
    Bailey, Aidan
    Pucci, Logan
    Dhindsa, Justin
    Robinson-Hamm, Jacqueline
    Gersbach, Charles
    ElMallah, Mai
    [J]. FASEB JOURNAL, 2021, 35
  • [5] Effect of treatment with grow factors on muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Nielsen, T.
    Pinos, T.
    Krag, T.
    Vissing, J.
    [J]. NEUROMUSCULAR DISORDERS, 2015, 25 : S291 - S291
  • [6] Eosinophils Do Not Drive Acute Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy
    Sek, Albert C.
    Moore, Ian N.
    Smelkinson, Margery G.
    Pak, Katherine
    Minai, Mahnaz
    Smith, Roberta
    Ma, Michelle
    Percopo, Caroline M.
    Rosenberg, Helene F.
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 203 (02): : 476 - 484
  • [7] Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020
    Whitehead, N. P.
    Kim, M. J.
    Bible, K. L.
    Adams, M. E.
    Froehner, S. C.
    [J]. JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (05) : 865 - 866
  • [8] Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
    Hori, Yusuke S.
    Kuno, Atsushi
    Hosoda, Ryusuke
    Tanno, Masaya
    Miura, Tetsuji
    Shimamoto, Kazuaki
    Horio, Yoshiyuki
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (03): : 784 - 794
  • [9] Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Milad, Nadia
    White, Zoe
    Tehrani, Arash Y.
    Sellers, Stephanie
    Rossi, Fabio M. V.
    Bernatchez, Pascal
    [J]. SKELETAL MUSCLE, 2017, 7
  • [10] Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular Dystrophy
    Paleo, Brian J.
    McElhanon, Kevin E.
    Bulgart, Hannah R.
    Banford, Kassidy K.
    Beck, Eric X.
    Sattler, Kristina M.
    Goines, Briana N.
    Ratcliff, Shelby L.
    Crowe, Kelly E.
    Weisleder, Noah
    [J]. CELLS, 2022, 11 (09)